Quick Answer
RELMADA THERAPEUTICS, INC. reported Total Assets of $94.00 million for fiscal year 2025.
RELMADA THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $94.00M | +105.2% |
| 2024 | $45.82M | -53.0% |
| 2023 | $97.55M | -36.2% |
| 2022 | $152.91M | -31.5% |
| 2021 | $223.33M | +89.0% |
| 2020 | $118.19M | +0.9% |
| 2019 | $117.14M | +1046.2% |
| 2019 | $10.22M | +235.3% |
| 2018 | $3.05M | +7.4% |
| 2017 | $2.84M | -72.3% |
| 2016 | $10.24M | -58.0% |
| 2015 | $24.39M | -5.3% |
| 2014 | $25.76M | +128664.3% |
| 2013 | $20.0K | +9.0% |
| 2012 | $18.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.88M | -73.3% | -29.6% |
| June 30, 2025 | $21.12M | -70.3% | -23.7% |
| March 31, 2025 | $27.68M | -67.2% | -39.6% |
| December 31, 2024 | $45.82M | -53.0% | -17.8% |
| September 30, 2024 | $55.72M | -48.9% | -21.5% |
| June 30, 2024 | $71.03M | -41.8% | -15.9% |
| March 31, 2024 | $84.41M | -37.7% | -13.5% |
| December 31, 2023 | $97.55M | -36.2% | -10.6% |
- RELMADA THERAPEUTICS, INC. showed an increase of +105.2% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, RELMADA THERAPEUTICS, INC.’s total assets has grown by 512068.9% (from $18.4 thousand to $94.00 million).
- The most recent figure is from RELMADA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: